Publications

<<Back to Project

CATHERINE POH'S PUBLICATION

1. Ye A, Ho C, Liu YK, Poh CF, Wu J. Is radiation with cetuximab an effective treatment in HPV positive head and neck squamous cell carcinoma? Radiotherapy & Oncology. February 2013, Volume 106, Suppliment 1, S52.

2. Hallani SE, Poh CF, MacAulay C, Follen M, Guillaud M, Lane P. Ex Vivo Confocal Imaging with Contrast Agents for the Detection of Oral Potentially Malignant Lesions. Oral Oncology, OO-D-12-809R1. (Article in press, e-pub date: Febrary 12, 2013)

3. Macdonald D, Gu Y, Zhang L, Poh CF. Canc Clinical and Radiological Features Predict Recurrence in Solitary Keratocystoic Odontogenic Tumors? Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endotology, 2013, 115 (2): 63-271.

4. Zhang L, Poh CF, Williams M, Laronde DM, Berean K, Gardner PJ, Jiang H, Lang W, Lee JJ, Rosin MP. Loss of Heterozygosity (LOH) Profile - Validated Risk Predictors for Progression to Oral Cancer. Cancer Prevention Research 2012, 5(9):1081-9 [IF=4.908]

5. MacAulay C, Poh CF, Guillaud M, Williams PM, Laronde DM., Zhang L, Rosin, MP. High Throughput Image Cytometry Platform for Detection of Suspicious Lesions in the Oral Cavity. Journal of Biomedical Optics 2012;17(8), 086004. [IF=3.480]

6. Lin Jun R., Lubpairee T., Liu KY, Anderson DW, Durham S, Poh CF. Cyclin D1 Overexpression is Associated with Poor Prognosis in Oropharyngeal Cancer. (Manuscript in preparation to submit to Canadian Otolaryngology Surgery Journal).

7. Saini R., Poh CF. Topical photodynamic therapy: A review and its prospective role in the management of oral potentially malignant disorders. Oral Diseases, 2012, doi: 10.1111/odi.12003

8. MacLellan S, Lawson J, Baik J, Guillaud M, Poh CF, Garnis C. Differential Expression of miRNAs in the Serum of Patients with High-risk Oral Lesions. Cancer Medicine (Accepted, June 13, 2012)

9. Poh CF, Zhu Y, Chen E, Berean KW, Wu L, Zhang L, Rosin MP. Unique FISH Patterns Associated with Cancer Progression of Oral Dysplasia. J Dent Res 2012, 91 (1):52-57. [IF=3.773]

10. Poh CF, Durham JS, Brasher PM, Anderson DW, Berean KW, MacAulay CE, Lee JJ, Rosin MP.  Canadian Optically-guided approach for Oral Lesions Surgical (COOLS) trial:  Study protocol for a randomized controlled trial. BMC Cancer 2011, 11:462. [IF=3.15]

11. Gorenchtein M, Poh CF, Saini R, Garnis C. MicroRNAs in an Oral Cancer Context – from Basic Biology to Clinical Utility. J Dent Res 2011; 91(5):440-6). [IF=3.773]

12. Poh CF, MacAulay CE, Laronde DM, Williams PM, Zhang L, Rosin MP. Squamous cell carcinoma and precursor lesions: Diagnosis and screening in a technical era. Periodontology 2000, 2011; 57:1- 16. [IF=2.082]

13. Auluck A, Hislop G, Bajdik C, Zhang L, Poh C, Rosin M. Trends in oral cancer incidence in a multicultural region: the BC experience. Cancer, 2010;116 (11):2635-44. [IF=5.131]

14. Zhang LL, Yang R, Zhang L, Li W, MacDonald-Jankowski D, Poh CF. Dentigerous cyst: a retrospective clinicopathological analysis of 2,082 dentigerous cysts in British Columbia, Canada. International Journal of Oral and Maxillofacial Surgery 2010;39: 878–882. [IF=1.302]

15. Gu Y, Williams P.M, Poh CF. How do I evaluate a patient with a swollen lip? J Can Dent Assoc 2010:76:a92. [IF=1.320]

16. Tsui IL, Garnis C, Poh CF. A Dynamic Oral Cancer Field: Unraveling the Underlying Biology and Its Clinical Implication.  American Journal of Surgical Pathology, 2009; 33 (11): 1732-1738. [IF=4.106]

17. Auluck A, Hislop G, Poh C, Zhang L, Rosin MP. Areca nut and betel quid chewing among South Asian immigrants to Western countries and its implications for oral cancer screening. Rural Remote Health, 2009; 9(2):1118-21. [IF=0.931]

18. Poh CF, MacAulay CE, Zhang L, Rosin MP.  Tracing the “At-Risk” Oral Mucosa Field with Autofluorescence: Steps Toward Clinical Impact. Cancer Prevention Research, 2009; 2(5):401-404. [IF=4.978]

19. Tsui IL, Poh CF, Garnis C, Rosin MP, Zhang L, Lam WL. Multiple pathways in the FGF signaling network are frequently deregulated by gene amplification in oral dysplasias. International Journal Cancer, 2009; 125(9): 2219-2228. *Cited 11 times by February 01, 2012.[IF=4.926]

20. Poh CF, Ng S, Berean KW, Williams PM, Rosin MP, Zhang L. Biopsy and Histopathological Diagnosis of Oral Premalignant and Malignant Lesions. J Can Dent Assoc, 2008; 74(3): 283-288. [IF=1.320]

21. Guillard M, Zhang L, Poh CF, Rosin MP, MacAulay C. Potential Use of Quantitative Tissue Phenotype to Predict Malignant Risk for Oral Premalignant Lesions. Cancer Res, 2008; 68(9): 1-9. [IF=8.234]

22. Rosin MP, Poh CF, Elwood M, Williams PM, Gallagher R, MacAulay C, Lam WL, Auluck A, Zhang L, Hislop TG. New Hope for Oral Cancer Solutions: Together We Can Make a Difference. J Can Dent Assoc, 2008; 74(3): 261-266. [IF=1.320]

23. Williams PM, Poh CF, Hovan A, Ng PS, Rosin MP. Evaluation of a suspicious oral mucosal lesion. J Can Dent Assoc, 2008; 74(3): 275-280. [IF=1.320]

24. Currie LB, Williams PM, Poh CF. Is the message clear? Talking with your patient about oral cancer screening. J Can Dent Assoc, 2008; 74(3): 255-256. [IF=1.320]

25. Poh CF, Ng S, Berean KW, Williams PM, Rosin MP, Zhang L. Biopsy and Histopathological Diagnosis of Oral Premalignant and Malignant Lesions. J Can Dent Assoc, 2008; 74(3): 283-288.

26. Biggar H, Poh CF, Rosin MP, Williams PM. The Voice of An Oral Cancer Patient. J Can Dent Assoc, 2008; 74(3): 237-238. [IF=1.320]

27. Laronde DM, Bottorff J, Hislop TG, Poh CF, Currie LB, Williams PM, Rosin MP. Experiences from the Dental Office: Initiating Oral Cancer Screening. J Can Dent Assoc, 2008; 74(3): 239-241. [IF=1.320]

28. British Columbia Oral Cancer Prevention Program - The early detection of oral cancer working group, BC Oral Cancer Prevention Program. Guideline for the Early Detection of Oral Cancer in British Columbia 2008. J Can Dent Assoc, 2008; 74(3): 245-52 (Invited publication by the College of Dental Surgeons of British Columbia). [IF=1.320]

29. Poh CF, Ng SP, Williams PM, Zhang L, Laronde DM, Lane P, Macaulay C, Rosin MP. Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device. Head Neck, 2007; 29(1): 71-6. [IF=2.182]

30. Poh CF, Hislop TG, Currie B, Lee R, Sikorski S, Zed C, Zhang L, MacAulay C, Rosin MP.  Oral Cancer Screening in the Vancouver Downtown Eastside -- a High-Risk Underserved Population. J Health Care for the Poor and Underserved,2007; 18: 767-778. [IF=0.964]

31. Gratzinger D, Salama ME, Poh CF, Rouse RV. Ameloblastoma, calcifying epithelial odontogenic tumor, and glandular odontogenic cyst show a distinctive immunophenotype with some myoepithelial antigen expression. J Oral Pathol Med, 2007; 37(3): 177-84. [IF=2.075]

32. Biggar H, Forrest A, Poh CF. Global Oral Cancer Screening Programs- Review and Recommendations. Can J Dent Hyg, 2007; 41(3): 138-146.

33. Laronde DM, Poh CF, William M, Hislop TG, Zhang L, MacAulay C, Rosin MP. A Magic Wand for the Community Dental Office? Observations from the British Columbia Oral Cancer Prevention Program. J Can Dent Assoc, 2007; 73(7): 607-610. [IF=1.320]

34. Poh CF, Ng SP, Williams PM, Zhang L, Laronde DM, Lane P, MacAulay C, Rosin MP.  Detection of clinically occult high-risk oral premalignant disease using direct autofluorescent visualization. Head Neck, 2007; 29(1): 71-6. [IF=2.182]

35. Rosin MP, Poh CF, Guillard M, Williams M, Zhang L, MacAulay C.  Visualization and other emerging technologies as changes-makers for oral cancer prevention.  J New York Acad Sci, 2007; 1098: 167-183. [IF=2.847]

36. Ng SP, Poh CF, Williams PM, Zhang L, Macaulay C, Rosin MP.  Use of Direct Fluorescence Visualization to Identify High-Risk Oral Pre-malignant Lesions in British Columbia: Update.  Inside Dentistry, 2007; 3(4, Supplement), 199: 19-20. 

37. Poh CF, Zhang L, Anderson DW, Durham S, Williams PM, Ng S, Priddy RW, Tseng IL, MacAulay C. Rosin MP.  Fluorescence Visualization Detection of Field Alterations in Margins of Oral Cancer Patients. Clin Can Res, 2006; 12(24): 6716-22. (See Editorial on the article: Westra and Sidransky.  Fluorescence visualization as a means to establish the extent of oral neoplasia including its relationship to the surgical margins: shedding new light on an old problem. Clinical Cancer Research, 2006, 12(24): 6594-97, Biology Behind). *Cited 24 times by July 26, 2009.

38. Lane MP, Gilhuly T, Whitehead P, Zheng H, Poh CF, Ng S, Williams PM, Zhang L, Rosin M, MacAulay CE. Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Optics, 2006; 11(2): 024006 (1-7). *Cited 33 times by July 26, 2009.

39. Poh CF, William PM, Zhang L, Rosin MP. Heads-up! – A Call for Dentists for Oral Cancer. J Can Dent Assoc, 2006; 72(5): 413-416.

40. Zhang L, William PM, Poh CF, Laronde D, Epstein JB, Durham S, Nakamura H, Berean K, Hovan A, Le ND, Hislop G, Priddy R, Hay J, Lam WL, Rosin MP.  Toluidine blue staining identifies primary oral premalignant lesions with high molecular risk of progression. Can Res, 2005; 65(17): 8017-8021. (AACR made a news release regarding this study on Sept. 1, 2005: Vanderboom R, ‘Dye Imaging ID’s Oral Lesions Likely to Become Cancer’). *Cited 33 times by July 26, 2009.

41. Poh CF and Priddy RW.  Oral acquired lymphangioma circumscriptum mimicking verrucous carcinoma. Oral Oncology Extra, 2005; 41: 277-280.

42. Ektefaie MR, David HT, Poh CF. Surgical Resolution of Chronic Tissue Irritation Caused by Extruded Endodontic Filling Material. J Can Dent Assoc, 2005; 71(7): 487-90.

43. Poh CF, Priddy RW, Dahlman DM.  Intramandibular Inflammatory Myofibroblastic Tumor- a True Neoplasm or Reactive Lesion? Oral Surg Oral Med Oral Path Oral Radiol Endod, 2005; 100(4): 460-466.

44. Khoury H, Poh CF, William M, Lavoie JC, Nevill TJ.  Acute myelogenous leukemia complicated by acute necrotizing ulcerative gingivitis due to Aspergillus terreus.  Leuk lymphoma, 2003; 44(4): 709-13.

45. Epstein JB, Zhang L, Poh CF, Nakamura H, Berean K and Rosin MP.  Increased allelic loss in toluidine blue positive oral premalignant lesions.  Oral Surg Oral Med Oral Path, 2003; 95: 45-50. Cited 20 times by July 26, 2009.

46. Rosin MP, Lam WL, Poh CF, Le ND, Li RJ, Zeng T, Priddy R, and Zhang L. 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. Cancer Res, 2002; 62(22): 6447-50 *Cited 24 times by July 26, 2009.

47. Zhang L, Epstein JB, Poh CF, Berean K, Lam WL, Zhang X, Rosin MP.  Comparison of HPV infection, p53 mutation and allelic losses in post-transplant and non-posttransplant oral squamous cell carcinomas.  J Oral Pathol Med, 2002; 31(3): 134-41. *Cited 14 times by July 26, 2009.

48. Al-Ghamdi A, Freedman D, Miller D, Poh CF, Rosin MP, Zhang L, Gilks CB. Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases. Gynecol Oncol, 2002; 84(1): 94-101. *Cited 62 times by July 26, 2009.

49. Poh CF, Zhang L, Lam WL, Zhang X, An D, Chau C, Priddy R, Epstein J, Rosin MP.  A high frequency of allelic loss in oral verrucous lesions may explain malignant risk.  Lab Inves, 2001; 81: 629-634. *Cited 12 times by July 26, 2009.

50. Zhang L, Poh CF, Lam WL, Epstein JB, Cheng X, Zhang X, Priddy R, Lovas J, Le ND and Rosin MP.  Impact of localized treatment in reducing risk of progression of low-grade oral dysplasia: molecular evidence of incomplete resection.  Oral Oncol, 2001; 37: 505-512. *Cited 21 times by July 26, 2009.

51. Zhang L, Cheung K-J, Lam WL, Cheng X, Poh CF, Priddy R, Epstein J, Le ND, Rosin MP.  Increased genetic damage in oral leukoplakia from high-risk sites: potential impact on staging and clinical management.  Cancer, 2001; 91(11): 2148-55. *Cited 16 times by July 26, 2009

52. Rosin MP, Cheng X, Poh CF, Lam WL, Huang Y, Lovas J, Berean K, Epstein JB, Priddy R, Le ND and Zhang L.  Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.  Clin Can Res, 2000; 6(2): 357-362.  (Editorial on the article: Mao L. Can Molecular Assessment Improve Classification of Head and Neck Premalignancy? Clinical Cancer Research, 2000, 6(2): 321-2.) *Cited 159 times by July 26, 2009

53. Zhang L, Cheng X, Li Y, Poh CF, Zeng T, Priddy R, Lovas J, Freedman P, Daley T, Rosin MP.  High frequency of allelic loss in dysplastic lichenoid lesions.  Lab Inves, 2000; 80(2): 233-7.  *Cited 17 times by July 26, 2009.

BOOK / BOOK CHAPTERS

• 1. Poh CF. Microsatellite studies of oral cancer and premalignant lesions. LAP Lambert Academic Publishing. ISBN 978-3-8454-2831-4

  2. Rosin MP, Poh CF, Kang C, MacAulay CE, Zhang L. Progress in Early Detection and Management of Oral Dysplasia: Components for a Multifaceted Progression Risk Model. In : Advances in Understanding the Basic Pathogenesis and Clinical Management of Pre-invasive Disease." Springer Science (Submitted in Feb. 2010).

  3. Poh CF, Lane P, MacAulay C, Zhang L, Rosin MP.  The application of tissue autofluorescence in detection and management of oral cancer and premalignant lesions. In: Optical Imaging of Cancer: Enhancing Detection and Resection, Rosenthel ELand Zinn KR (eds), Springer Science and Business Media. pp. 101-18, 2009.

  4. Rosin MP, Zhang L, and Poh CF. Molecular markers of oral premalignant lesion risk. In: Head and Neck Cancer Emerging Perspectives, J.F. Ensley, J. S. Gutkind, J.R. Jacobs and S.M. Lippman, (eds), Academic Press, Calif., pp.245-259, 2003.